Supported by: Geneva Cancer League, CARIGEST SA, La Fondation pour la Lutte contre le Cancer et pour des Recherches Médico-biologiques, L′association “Le Printemps des Enfants” (Geneva, Switzerland).
GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma†
Article first published online: 1 NOV 2011
Copyright © 2011 Wiley-Liss, Inc.
Genes, Chromosomes and Cancer
Volume 51, Issue 2, pages 174–185, February 2012
How to Cite
Gumy-Pause, F., Pardo, B., Khoshbeen-Boudal, M., Ansari, M., Gayet-Ageron, A., Sappino, A.-P., Attiyeh, E. F. and Ozsahin, H. (2012), GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma. Genes Chromosom. Cancer, 51: 174–185. doi: 10.1002/gcc.20941
- Issue published online: 7 DEC 2011
- Article first published online: 1 NOV 2011
- Manuscript Accepted: 26 SEP 2011
- Manuscript Received: 23 JUN 2011
This article has been cited by:
- 1MicroRNA Regulating Glutathione S-Transferase P1 in Prostate Cancer, Current Pharmacology Reports, 2015, 1, 2, 79, , ,
- 3Adiponectin in inflammatory and immune-mediated diseases, Cytokine, 2013, 64, 1, 1,
- 4Epigenetic-dependent regulation of drug transport and metabolism: an update, Pharmacogenomics, 2012, 13, 12, 1373, , ,